E. Stamellou

发表

N-Octanoyl Dopamine Inhibits the Expression of a Subset of κB Regulated Genes: Potential Role of p65 Ser276 Phosphorylation

C. Sticht, B. Yard, M. Hafner, 2013, PloS one.

Effects of Perfusion Pressures on Podocyte Loss in the Isolated Perfused Mouse Kidney.

Victor G. Puelles, P. Boor, J. Floege, 2021, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

N-acyl dopamine derivates as lead compound for implementation in transplantation medicine.

B. Yard, J. Wedel, E. Stamellou, 2015, Transplantation reviews.

Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation

J. Floege, E. Stamellou, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

What We Have Learned so far From Single Cell Sequencing in Acute Kidney Injury

M. Buse, M. Moeller, E. Stamellou, 2022, Frontiers in Physiology.

N-Octanoyl Dopamine Treatment of Endothelial Cells Induces the Unfolded Protein Response and Results in Hypometabolism and Tolerance to Hypothermia

C. Sticht, B. Krämer, B. Yard, 2014, PloS one.

University of Groningen N-Octanoyl Dopamine Treatment of Endothelial Cells Induces the Unfolded Protein Response and Results in Hypometabolism and Tolerance to Hypothermia Stamellou,

C. Sticht, B. Krämer, B. Yard, 2014 .

Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study

T. Rauen, J. Floege, K. Lenaerts, 2022, Journal of Nephrology.

Synthesis and Performance of Acyloxy-diene-Fe(CO)3 Complexes with Variable Chain Lengths as Enzyme-Triggered Carbon Monoxide-Releasing Molecules

B. Yard, Miguel Guttentag, R. Alberto, 2013 .

Dopamine treatment of brain-dead Fisher rats improves renal histology but not early renal function in Lewis recipients after prolonged static cold storage.

H. Wenz, B. Yard, S. Hoeger, 2014, Transplantation proceedings.

Iron Dienylphosphate Tricarbonyl Complexes as Water-Soluble Enzyme-Triggered CO-Releasing Molecules (ET-CORMs)

B. Yard, Miguel Guttentag, R. Alberto, 2012 .

Precision medicine in immunoglobulin A nephropathy: still a journey ahead.

T. Rauen, J. Floege, E. Stamellou, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Regenerating tubular epithelial cells of the kidney.

M. Moeller, E. Stamellou, Katja Leuchtle, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Enzyme-triggered CO-releasing molecules (ET-CORMs): evaluation of biological activity in relation to their structure.

B. Krämer, B. Yard, M. Hafner, 2013, Free radical biology & medicine.

N‐Octanoyl dopamine transiently inhibits T cell proliferation via G1 cell‐cycle arrest and inhibition of redox‐dependent transcription factors

J. Hillebrands, B. Yard, A. Breedijk, 2014, Journal of leukocyte biology.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.

E. Manios, E. Stamellou, I. Chouliarás, 2011, Artificial organs.

Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation

B. Krämer, B. Yard, M. Hafner, 2014, Redox biology.

TESTING the effects of corticosteroids in patients with IgA nephropathy.

T. Rauen, J. Floege, E. Stamellou, 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

N‐Octanoyl dopamine transiently inhibits T cell proliferation via G1 cell‐cycle arrest and inhibition of redox‐dependent transcription factors

J. Hillebrands, B. Yard, A. Breedijk, 2014, Journal of leukocyte biology.

IgA nephropathy

E. Stamellou, C. Seikrit, R. Kramann, 2023, Nature Reviews Disease Primers.

Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort

E. Stamellou, Turgay Saritas, Marc Froissart, 2024, BMC nephrology.

Long-term outcomes of patients with IgA nephropathy in the German CKD cohort

E. Stamellou, A. Mercer, C. Seikrit, 2024, Clinical kidney journal.

Lineage tracing reveals transient phenotypic adaptation of tubular cells during acute kidney injury

Mingbo Cheng, R. Kramann, T. Ostendorf, 2024, iScience.

Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species

C. Kuppe, N. Endlich, E. Stamellou, 2023, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.